<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03557476</url>
  </required_header>
  <id_info>
    <org_study_id>Octacosanol</org_study_id>
    <nct_id>NCT03557476</nct_id>
  </id_info>
  <brief_title>Effects of Octacosanol During Taekwondo Training</brief_title>
  <official_title>Octacosanol Supplementation Improves Lipid Profiles and Oxidative Stress During Rapid Weight Loss and High-Intensity Exercise in Taekwondo Athletes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska, Omaha</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska, Omaha</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Taekwondo players undergo rapid reductions of body weight prior to their competition in order
      to gain a size advantage over the opponent. However, these large weight changes with
      concomitant high intensity exercise training induce poor lipid profiles and high levels of
      oxidative stress, which can be detrimental to health and sports performance. Therefore, the
      purpose of this study was to investigate the ability of the nutritional supplement
      octacosanol to combat the physiological detriments that can occur from these rapid weight
      changes paired with high intensity exercise training.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Athletes that participate in weight division sports such as taekwondo, boxing, judo, and
      wrestling regularly reduce their body weight severely prior to competition in order to gain a
      size advantage over the opponent while simultaneously meeting their weight division
      requirements. In general, athletes have acute weight loss of 4-7 kg within 3-4 days of
      competition, while longer periods of more gradual weight loss of 15-22 kg lasting 3-4 weeks.
      Although this kind of extreme weight loss can induce metabolic dysfunction, it is repeatedly
      performed by athletes of weight division sports in order to acquire a more advantageous
      condition for play. Furthermore, athletes participating in matches tend to obtain excessive
      weights compared to their weight division during the offseason in order to lift heavier
      weights during training, and then rapidly lose that weight over a short period of time prior
      to competition, resulting in the deterioration of physiological function and possibly sports
      performance.

      Rapid weight loss with high intensity exercise training also increases oxygen free radical
      production to a point that exceeds the defense mechanism of antioxidant enzymes in the body
      and ultimately results in damage to the cells, specifically, the lipid peroxidation of cell
      membranes. Not only does this decrease physiological function, but sports performance can
      also decrease as oxidative stress increases due to an interference in metabolic activity, a
      reduction in vascular function and an increase in systemic inflammation. Octacosanol, a
      straight-chain, high-molecular-weight, primary aliphatic alcohol minimally contained in the
      germinal disks of rice bran, wheat and sugar cane, may be able to prevent these
      deteriorations as it has been shown to provide various health benefits. In fact, previous
      studies reported that pre-exercise octacosanol intake contributed to enhanced muscular
      strength, muscular endurance and oxygen transport ability. Additionally, octacosanol
      supplementation has been shown to improve cardiovascular endurance and heart function in
      patients with peripheral artery disease, improve levels of low-density and high-density
      lipoprotein-cholesterol in patients with hypercholesterolemia, and increase glycogen
      accumulation in mice9. However, the potential beneficial effects of octacosanol intake for
      reducing free radical production and preventing detrimental physiological function from
      excessive weight loss with high intensity exercise has not been examined. Thus, the purpose
      of this study was to investigate the effects of octacosanol supplementation during acute
      weight loss with high-intensity exercise training on lipid profiles and markers of oxidative
      stress in taekwondo players.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">March 1, 2018</completion_date>
  <primary_completion_date type="Actual">March 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma triglyceride levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Cholesterol</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma total cholesterol levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>High-density Lipoprotein</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma levels of high-density lipoprotein</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Low-density Lipoprotein</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma levels of low-density lipoprotein</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Malondialdehyde</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma levels of malondialdehyde</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Superoxide Dismutase</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma levels of superoxide dismutase</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glutathione Peroxidase</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma levels of glutathione peroxidase</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Oxidative Stress</condition>
  <condition>Dyslipidemias</condition>
  <arm_group>
    <arm_group_label>Octacosanol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Octacosanol</intervention_name>
    <description>One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
    <arm_group_label>Octacosanol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 3 years of experience in national taekwondo competitions

          -  abstain from caffeinated drinks, alcohol, and antioxidant supplements during the whole
             period of the study

        Exclusion Criteria:

          -  no history of chronic use of antioxidants, chronic aspirin, and nonsteroidal
             anti-inflammatory drugs (NSAIDs)

          -  No cardiovascular, neurological, metabolic or renal diseases

          -  no musculoskeletal injuries
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Song Park, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nebraska, Omaha</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nebraska at Omaha</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68182</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>June 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2018</study_first_posted>
  <results_first_submitted>March 27, 2019</results_first_submitted>
  <results_first_submitted_qc>August 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 12, 2019</results_first_posted>
  <last_update_submitted>August 8, 2019</last_update_submitted>
  <last_update_submitted_qc>August 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nebraska, Omaha</investigator_affiliation>
    <investigator_full_name>Song-Young Park</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Octacosanol</keyword>
  <keyword>Taekwondo</keyword>
  <keyword>Lipid Profiles</keyword>
  <keyword>Oxidative Stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 25, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/76/NCT03557476/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Octacosanol</title>
          <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Octacosanol</title>
          <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18" spread="1"/>
                    <measurement group_id="B2" value="18" spread="1"/>
                    <measurement group_id="B3" value="18" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>South Korea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="174.7" spread="1.4"/>
                    <measurement group_id="B2" value="173.9" spread="6.3"/>
                    <measurement group_id="B3" value="174.3" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.9" spread="6.7"/>
                    <measurement group_id="B2" value="66.7" spread="5.7"/>
                    <measurement group_id="B3" value="66.8" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body fat</title>
          <units>percentage of body fat</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8" spread="2"/>
                    <measurement group_id="B2" value="8" spread="2"/>
                    <measurement group_id="B3" value="8" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Triglycerides</title>
        <description>Plasma triglyceride levels</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Triglycerides</title>
          <description>Plasma triglyceride levels</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.9" spread="7.8"/>
                    <measurement group_id="O2" value="110" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Cholesterol</title>
        <description>Plasma total cholesterol levels</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Total Cholesterol</title>
          <description>Plasma total cholesterol levels</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="164" spread="12.8"/>
                    <measurement group_id="O2" value="173.5" spread="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>High-density Lipoprotein</title>
        <description>Plasma levels of high-density lipoprotein</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>High-density Lipoprotein</title>
          <description>Plasma levels of high-density lipoprotein</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71" spread="4.4"/>
                    <measurement group_id="O2" value="49.2" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Low-density Lipoprotein</title>
        <description>Plasma levels of low-density lipoprotein</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Low-density Lipoprotein</title>
          <description>Plasma levels of low-density lipoprotein</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.6" spread="8.1"/>
                    <measurement group_id="O2" value="114.9" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Malondialdehyde</title>
        <description>Plasma levels of malondialdehyde</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Malondialdehyde</title>
          <description>Plasma levels of malondialdehyde</description>
          <units>mmol/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="0.1"/>
                    <measurement group_id="O2" value="0.93" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Superoxide Dismutase</title>
        <description>Plasma levels of superoxide dismutase</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Superoxide Dismutase</title>
          <description>Plasma levels of superoxide dismutase</description>
          <units>U/gHb</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1450" spread="138.9"/>
                    <measurement group_id="O2" value="1010" spread="150.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glutathione Peroxidase</title>
        <description>Plasma levels of glutathione peroxidase</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Glutathione Peroxidase</title>
          <description>Plasma levels of glutathione peroxidase</description>
          <units>U/gHb</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.9" spread="10.8"/>
                    <measurement group_id="O2" value="47.1" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Octacosanol</title>
          <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Song-Young Park</name_or_title>
      <organization>The University of Nebraska at Omaha</organization>
      <phone>402-554-3374</phone>
      <email>song-youngpark@unomaha.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

